Press release
-
IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma
SHANGHAI and NANJING, China and PLEASANTON, Calif., Nov. 27, 2025 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical company dedicated…
Read More » -
Press Release
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ — GC Genome, a leading clinical genomics and liquid biopsy company, announced that…
Read More » -
Press Release
Biel Crystal Forges Integrated Future with Pioneering Vietnam Automotive Line
HONG KONG, Nov. 26, 2025 /PRNewswire/ — Biel Crystal is set to redefine the automotive supply chain in Southeast Asia.…
Read More » -
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
New addition strengthens SK Biopharmaceuticals’ radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration…
Read More » -
Press Release
DAHON’s Global Expansion: A Call to Collaborate on New Opportunities
TIANJIN, China, Nov. 26, 2025 /PRNewswire/ — DAHON, the world’s biggest maker of folding bicycles, jumped on its Hong Kong…
Read More » -
dynaCERT Announces $2M Non-Brokered Private Placement Financing
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO–(BUSINESS WIRE)–$DMJ #carbonemissions—dynaCERT Inc. (TSX: DYA)…
Read More »
